Ameliorating effects of sacral neuromodulation on gastric and small intestinal dysmotility mediated via a sacral afferent-vagal efferent pathway.
gastrointestinal motility
glucagon
rectal distention
sacral nerve neuromodulation
sacral nerve stimulation
Journal
Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
06
12
2019
revised:
04
02
2020
accepted:
18
02
2020
pubmed:
20
3
2020
medline:
16
7
2021
entrez:
20
3
2020
Statut:
ppublish
Résumé
In a recent study of sacral nerve stimulation (SNS) for colonic inflammation, a possible spinal-vagal pathway was implicated. The aim of this study was to provide evidence for such a pathway by investigating the effects of SNS on dysmotility of the stomach and duodenum that are not directly innervated by the sacral efferents. Twenty-seven rats were chronically implanted with wire electrodes for SNS and gastrointestinal slow waves. SNS was performed in several acute sessions to investigate its effects on gastric/duodenal slow waves and emptying/transit impaired by glucagon and rectal distention (RD). (a) SNS increased the percentage of normal gastric slow waves impaired by glucagon (from 53.9% to 77.0%, P < .0001) and RD (from 64% to 78%, P = .037). This improvement was abolished by atropine. (b) Similar effects were observed with SNS on duodenal slow waves, which was also blocked by atropine. (c) SNS normalized delayed gastric emptying induced by glucagon (control: 61.3%, glucagon: 44.3%, glucagon + SNS: 65.8%) and RD (control: 61.3%, RD: 46.7%, RD + SNS: 64.3%). It also normalized small intestinal transit delayed by RD (P = .001, RD + SNS vs RD; P = .9, RD + SNS vs control). (4) Both glucagon and RD induced an increase in the sympathovagal ratio (P = .007, glucagon vs baseline; P < .001, RD vs baseline) and SNS decreased the ratio (P = .006, glucagon + SNS vs glucagon; P = .04, RD + SNS vs RD). Neuromodulation of the sacral nerve improves gastric and small intestinal pacemaking activity and transit impaired by glucagon and RD by normalizing the sympathovagal balance via a retrograde neural pathway from the sacral nerve to vagal efferents.
Sections du résumé
BACKGROUND/AIMS
In a recent study of sacral nerve stimulation (SNS) for colonic inflammation, a possible spinal-vagal pathway was implicated. The aim of this study was to provide evidence for such a pathway by investigating the effects of SNS on dysmotility of the stomach and duodenum that are not directly innervated by the sacral efferents.
METHODS
Twenty-seven rats were chronically implanted with wire electrodes for SNS and gastrointestinal slow waves. SNS was performed in several acute sessions to investigate its effects on gastric/duodenal slow waves and emptying/transit impaired by glucagon and rectal distention (RD).
RESULTS
(a) SNS increased the percentage of normal gastric slow waves impaired by glucagon (from 53.9% to 77.0%, P < .0001) and RD (from 64% to 78%, P = .037). This improvement was abolished by atropine. (b) Similar effects were observed with SNS on duodenal slow waves, which was also blocked by atropine. (c) SNS normalized delayed gastric emptying induced by glucagon (control: 61.3%, glucagon: 44.3%, glucagon + SNS: 65.8%) and RD (control: 61.3%, RD: 46.7%, RD + SNS: 64.3%). It also normalized small intestinal transit delayed by RD (P = .001, RD + SNS vs RD; P = .9, RD + SNS vs control). (4) Both glucagon and RD induced an increase in the sympathovagal ratio (P = .007, glucagon vs baseline; P < .001, RD vs baseline) and SNS decreased the ratio (P = .006, glucagon + SNS vs glucagon; P = .04, RD + SNS vs RD).
CONCLUSIONS
Neuromodulation of the sacral nerve improves gastric and small intestinal pacemaking activity and transit impaired by glucagon and RD by normalizing the sympathovagal balance via a retrograde neural pathway from the sacral nerve to vagal efferents.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13837Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Keller J, Bassotti G, Clarke J, et al. Expert consensus document: advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol. 2018;15:291-308.
Parkman HP, Camilleri M, Farrugia G, et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010;22:113-133.
Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589-1591.
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-1479.
Stanghellini V. Functional dyspepsia and irritable bowel syndrome: beyond Rome IV. Dig Dis. 2017;35(Suppl 1):14-17.
Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-397.
Jones KL, Horowitz M, Wishart MJ, Maddox AF, Harding PE, Chatterton BE. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med. 1995;36:2220-2228.
Rothstein RD. Gastrointestinal motility disorders in diabetes mellitus. Am J Gastroenterol. 1990;85:782-785.
Antonucci A, Fronzoni L, Cogliandro L, et al. Chronic intestinal pseudo-obstruction. World J Gastroenterol. 2008;14:2953-2961.
Gabbard SL, Lacy BE. Chronic intestinal pseudo-obstruction. Nutr Clin Pract. 2013;28:307-316.
Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med. 1999;50:37-55.
Stein B, Everhart KK, Lacy BE. Treatment of functional dyspepsia and gastroparesis. Curr Treat Options Gastroenterol. 2014;12:385-397.
Parthasarathy G, Ravi K, Camilleri M, et al. Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterol Motil. 2015;27:1736-1746.
Thompson JS, Langenfeld SJ, Hewlett A, et al. Surgical treatment of gastrointestinal motility disorders. Curr Probl Surg. 2016;53:503-549.
Shada A, Nielsen A, Marowski S, et al. Wisconsin’s Enterra Therapy experience: a multi-institutional review of gastric electrical stimulation for medically refractory gastroparesis. Surgery. 2018;164:760-765.
Gonzalez HC, Velanovich V. Enterra Therapy: gastric neurostimulator for gastroparesis. Expert Rev Med Devices. 2010;7:319-332.
Lu K-H, Cao J, Oleson S, et al. Vagus nerve stimulation promotes gastric emptying by increasing pyloric opening measured with magnetic resonance imaging. Neurogastroenterol Motil. 2018;30:e13380.
Bonaz B, Sinniger V, Pellissier S. Vagal tone: effects on sensitivity, motility, and inflammation. Neurogastroenterol Motil. 2016;28:455-462.
Wald A. Update on the management of fecal incontinence for the gastroenterologist. Gastroenterol Hepatol. 2016;12:155-164.
Abello A, Das AK. Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects. Ther Adv Urol. 2018;10:165-173.
Kamm MA, Dudding TC, Melenhorst J, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010;59:333-340.
Widmann B, Galata C, Warschkow R, et al. Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study. J Neurogastroenterol Motil. 2019;25(1):159-170.
Siegel S, Paszkiewicz E, Kirkpatrick C, Hinkel B, Oleson K. Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol. 2001;166:1742-1745.
Woodruff D, Bengtson C, Wilson B, Griebling T. 1511 outcomes of sacral nerve stimulation in patients with or without interstitial cystitis/chronic pelvic pain syndrome. J Urol. 2011;185:e606. https://doi.org/10.1016/j.juro.2011.02.1490
Langlois L, Meleine M, Ouelaa W, et al. Acute sacral nerve stimulation reduces visceral mechanosensitivity in Rat through spinal opioid pathway. Neurogastroenterol Motil. 2015;27:816-823.
Zhang H, Zhang N, Zhang S, Yin J, Pasricha PJ, Chen J. Autonomic-cytokine mechanisms of sacral nerve stimulation for intestinal inflammation: a preliminary rodent study using dextran sodium sulfate. Gastroenterology. 2017;152:S569.
Meng Y, Gharibani P, Maisiyiti A, Zhang Y, Chen J. Su1886 - Sacral nerve stimulation inhibits the Mapk/Nf-Kb signaling pathway and promotes Treg-Th1/17 cell balance in Tnbs-induced inflammation in rats. Gastroenterology. 2019;156:S-649.
Kenefick NJ. Sacral nerve neuromodulation for the treatment of lower bowel motility disorders. Ann R Coll Surg Engl. 2006;88:617-623.
Huang Z, Li S, Foreman RD, Yin J, Dai N, Chen JD. Sacral nerve stimulation with appropriate parameters improves constipation in rats by enhancing colon motility mediated via the autonomic-cholinergic mechanisms. Am J Physiol Gastrointest Liver Physiol. 2019;317:G609-G617.
Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg. 2013;100:959-968.
Feng Y, Liu Y, Li S, Zhang S, Foreman R, Chen JDZ. Sacral nerve stimulation increases gastric accommodation in rats: a spinal-afferent and vagal-efferent pathway. Am J Physiol Gastrointest Liver Physiol. 2019;318(6):G574-G581.
Tu L, Zhang H, Gharibani P, Zhang N, Yin J, Chen J. 1048 - centrally mediated vagal efferent pathway involved in anti-inflammatory effects of sacral nerve stimulation. Gastroenterology. 2018;154(6):S-198.
Ouyang X, Li S, Foreman R, et al. Hyperglycemia-induced small intestinal dysrhythmias attributed to sympathovagal imbalance in normal and diabetic rats. Neurogastroenterol Motil. 2015;27:406-415.
Zhang Z, Yin J, Chen JDZ. Ameliorating effects of auricular electroacupuncture on rectal distention-induced gastric dysrhythmias in rats. PLoS One. 2015;10:e0114226.
Chen J, Song G-Q, Yin J, Koothan T, Chen JDZ. Electroacupuncture improves impaired gastric motility and slow waves induced by rectal distension in dogs. Am J Physiol Gastrointest Liver Physiol. 2008;295:G614-G620.
Sun Y, Song G, Yin J, et al. Effects and mechanisms of electroacupuncture on glucagon-induced small intestinal hypomotility in dogs. Neurogastroenterol Motil. 2010;22:1217-1223, e318.
Zhu H, Sallam H, Chen DD, Chen JDZ. Therapeutic potential of synchronized gastric electrical stimulation for gastroparesis: enhanced gastric motility in dogs. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1875-R1881.
Hino K, Honjo H, Nakao M, Kitakoji H. The effects of sacral acupuncture on acetic acid-induced bladder irritation in conscious rats. Urology. 2010;75:730-734.
Jammes Y, Joulia F, Steinberg JG, et al. Endogenous adenosine release is involved in the control of heart rate in rats. Can J Physiol Pharmacol. 2015;93:667-675.
Guo J, Jin H, Shi Z, Yin J, Pasricha T, Chen JDZ. Sacral nerve stimulation improves colonic inflammation mediated by autonomic-inflammatory cytokine mechanism in rats. Neurogastroenterol Motil. 2019;31:e13676.
Chen JZ. Electrogastrography: Principles and Applications. Philadelphia, PA: Lippincott Williams & Wilkins; 1994.
Malysz J, Donnelly G, Huizinga JD. Regulation of slow wave frequency by IP(3)-sensitive calcium release in the murine small intestine. Am J Physiol Gastrointest Liver Physiol. 2001;280:G439-G448.
Weisbrodt NW, Sussman SS, Stewart JJ, Burks TF. Effect of morphine sulfate on intestinal transit and myoelectric activity of the small intestine of the rat. J Pharmacol Exp Ther. 1980;214:333-338.
Yin J, Chen J, Chen JDZ. Ameliorating effects and mechanisms of electroacupuncture on gastric dysrhythmia, delayed emptying, and impaired accommodation in diabetic rats. Am J Physiol Gastrointest Liver Physiol. 2010;298:G563-G570.
Wang X, Yang B, Yin J, Wei W, Chen JDZ. Electroacupuncture via chronically implanted electrodes improves gastrointestinal motility by balancing sympathovagal activities in a rat model of constipation. Am J Physiol Gastrointest Liver Physiol. 2019;316(6):G797-G805.
Sallam HS, Oliveira HM, Gan HT, Herndon DN, Chen JDZ. Ghrelin improves burn-induced delayed gastrointestinal transit in rats. Am J Physiol Regul Integr Comp Physiol. 2007;292:R253-R257.
Hou X, Yin J, Liu J, Pasricha PJ, Chen JDZ. In vivo gastric and intestinal slow waves in W/Wv mice. Dig Dis Sci. 2005;50:1335-1341.
Kulkarni N. Blood supply and nerve supply of heart. In: Saxena R, ed.Clinical Anatomy for Students: Problem Solving Approach. New Delhi, India: Jaypee Brothers Medical Publishers; 2006;268-271.
Brunton L, Lazo J, Parker K. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, Eleventh Edition. New York, NY: McGraw Hill Professional; 2005271.
Qin K, Dong C, Wu G, Lambert NA. Inactive-state preassembly of Gq-coupled receptors and Gq heterotrimers. Nat Chem Biol. 2011;7:740-747.
Rang HP, Maureen Dale M. Pharmacology. London, UK: Churchill Livingstone; 2003.
Fukuda H, Tsuchida D, Koda K, Miyazaki M, Pappas TN, Takahashi T. Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract. J Gastroenterol Hepatol. 2007;22:1293-1299.
Smith-Edwards KM, Najjar SA, Edwards BS, Howard MJ, Albers KM, Davis BM. Extrinsic primary afferent neurons link visceral pain to colon motility through a spinal reflex in mice. Gastroenterology. 2019;157:522-536.e2.
Beckett EAH, McGeough CA, Sanders KM, Ward SM. Pacing of interstitial cells of Cajal in the murine gastric antrum: neurally mediated and direct stimulation. J Physiol. 2003;553:545-559.
Hirst GD, Dickens EJ, Edwards FR. Pacemaker shift in the gastric antrum of guinea-pigs produced by excitatory vagal stimulation involves intramuscular interstitial cells. J Physiol. 2002;541:917-928.
Suzuki H, Ward SM, Bayguinov YR, Edwards FR, Hirst GD. Involvement of intramuscular interstitial cells in nitrergic inhibition in the mouse gastric antrum. J Physiol. 2003;546:751-763.
Soykan I, Sarosiek I, Sivri B, McCallum RW. Demographic, clinical characteristics psychologic profiles, treatment, long-term follow-up of patients with gastro-paresis. South Med J. 1998;91(Suppl):S37.